Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
PCN127 Cost-Utility Analysis of Newer HER2-...
Conference

PCN127 Cost-Utility Analysis of Newer HER2- Testing Technologies to Target Trastuzumab in the Adjuvant Breast Cancer Setting

Authors

Ferrusi IL; Kulin NA; Goeree R; Leighl N; Pullenayegum EM; Phillips K; Marshall D

Volume

17

Publisher

Elsevier

Publication Date

May 2014

DOI

10.1016/j.jval.2014.03.522

Conference proceedings

Value in Health

Issue

3

ISSN

1098-3015